[Nifedipine in preeclampsia for cesarean section]

Area of Science:

• Anesthesiology
• Obstetrics
• Pharmacology

Background:

• Preeclampsia patients undergoing cesarean section present anesthetic challenges due to potential hypertensive response post-intubation.
• Severe hypertension can lead to life-threatening complications like cerebral hemorrhage.
• Magnesium sulfate is commonly used for seizure prevention in these patients.

Purpose of the Study:

• To evaluate the efficacy of sublingual nifedipine in attenuating the pressor response to laryngoscopy and tracheal intubation.
• To assess the safety of nifedipine, specifically its effects on uterine contractions and postpartum hemorrhage when used with magnesium sulfate and general anesthesia.

Main Methods:

• A study involving thirty-three patients (16 in the nifedipine group, 17 in the control group).
• Administration of 10 mg sublingual nifedipine to the study group before intubation.
• Monitoring of hypertensive response, uterine contractions, blood loss, and maternal/fetal side effects.

Main Results:

• Nifedipine effectively attenuated the hypertensive response to intubation.
• Uterine contraction response to oxytocic drugs was adequate in both groups.
• No significant difference in blood loss or severe maternal/fetal adverse effects was observed between groups.

Conclusions:

• Sublingual nifedipine is an effective antihypertensive agent for managing the pressor response to intubation in preeclampsia patients.
• Nifedipine, when used with magnesium sulfate and general anesthesia, does not appear to inhibit uterine contractions or increase hemorrhage risk.
• Nifedipine offers a favorable safety profile for both mother and fetus in this context.